AG
PTX

Advisor Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Advisor Group’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-177
Closed – – 5501
2018
Q4 		$0 Hold
177
– – ﹤0.01% 5439
2018
Q3 		$0 Hold
177
– – ﹤0.01% 5393
2018
Q2 		$0 Hold
177
– – ﹤0.01% 5215
2018
Q1 		$0 Hold
177
– – ﹤0.01% 5233
2017
Q4 		$0 Hold
177
– – ﹤0.01% 5230
2017
Q3 		$1K Sell
177
-800
-82% -$2.57K ﹤0.01% 4802
2017
Q2 		$4K Buy
977
+800
+452% +$3.48K ﹤0.01% 4378
2017
Q1 		$1K Hold
177
– – ﹤0.01% 4654
2016
Q4 		$0 Sell
177
-1,799
-91% -$6.51K ﹤0.01% 4806
2016
Q3 		$12K Buy
1,976
+1,800
+1,023% +$11.1K ﹤0.01% 3486
2016
Q2 		$0 Buy
+176
New +$1.15K ﹤0.01% 4638

Advisor Group's PTX Position: Q1 2019 in Review

Advisor Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 177 shares.

Advisor Group first reported a position in PTX in Q2 2016 and held it in 11 quarters. The position peaked at $12K in Q3 2016. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.

  • Advisor Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
  • Advisor Group sold 177 Pernix Therapeutics Holdings, Inc. shares in Q1 2019.
  • Advisor Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2016 and held it in 11 quarters.
  • Advisor Group's Pernix Therapeutics Holdings, Inc. position peaked at $12K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.

Based on Advisor Group's 13F filing for Q1 2019, filed 9 May 2019.